| Joan S Janek, OT | |
|
450 Hope St, Bristol, RI 02809-1834 | |
| (401) 253-5314 | |
| (401) 253-5314 |
| Full Name | Joan S Janek |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 450 Hope St, Bristol, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801800735 | NPI | - | NPPES |
| 21383-7 | Other | RI | BLUE CROSS/BLUE SHEILD |
| 407436 | Other | RI | BLUE CHIP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT 00343 (Rhode Island) | Primary |
| 225X00000X | Occupational Therapist | 3051 (Rhode Island) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Joan S Janek, OT Po Box 671, Bristol, RI 02809-0671 Ph: (401) 253-5314 | Joan S Janek, OT 450 Hope St, Bristol, RI 02809-1834 Ph: (401) 253-5314 |
News Archive
Medically endorsed SIGVARIS created the Athletic Recovery Sock Line for competitive athletes and weekend warriors as compression garments have become highly visible in all major sports. Whether it's during the actual event, after the event, or even while traveling, athletes are making graduated compression socks part of their everyday attire.
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced preliminary results for two phase III trials evaluating Prochymal for the treatment of acute graft versus host disease (GvHD). GvHD, the most common complication of bone marrow transplantation, is a life-threatening disease for which there is currently no approved treatment. Prochymal showed significant improvements in response rates in difficult-to-treat liver and gastrointestinal GvHD, however neither trial reached its primary endpoint.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, Eq, 1.4 mg/0.36 mg and 5.7 mg/1.4 mg Base. Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.
Shares of four home health care providers tumbled Thursday after the Senate Finance Committee raised questions about how the companies bill Medicare for home health therapy visits, The Associated Press/ABC News reports.
A report of two young children with burns of the esophagus caused by swallowed button batteries from "fidget spinners" highlights a risk of severe injuries involving these popular toys, according to a series of reports in the January/February Journal of Pediatric Gastroenterology and Nutrition.
› Verified 9 days ago
James Perry, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 480 Metacom Avenue, Bristol, RI 02809 Phone: 401-253-8000 Fax: 401-942-3960 | |
Sylvia Magdelena Serafin I, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Dawn Hl, Bristol, RI 02809 Phone: 401-253-2300 | |
Mrs. Ashley Hayes Pereira, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 31 Duffield Rd, Bristol, RI 02809 Phone: 774-254-2943 | |
Emily Lauren Beck, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Walnut St, Bristol, RI 02809 Phone: 727-422-0315 |